Clinical Trials Browser

Phase 3 × Not yet recruiting × Olanzapine × Clear all

NCT07035821 2025-06-25

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

Phase 3 Not yet recruiting

Neoplasms, Vomiting